PAR4 COST-EFFECTIVENESS ANALYSIS OF RITUXIMAB AS A NEW THERAPEUTIC OPTION FOR RHEUMATOID ARTHRITIS IN THE UK
May 1, 2006, 00:00
10.1016/S1098-3015(10)64385-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)64385-9/fulltext
Title :
PAR4 COST-EFFECTIVENESS ANALYSIS OF RITUXIMAB AS A NEW THERAPEUTIC OPTION FOR RHEUMATOID ARTHRITIS IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64385-9&doi=10.1016/S1098-3015(10)64385-9
First page :
Section Title :
Open access? :
No
Section Order :
289